HIGHLIGHTS
- who: Alexandra Della Pia and collaborators from the Hackensack University Medical Center, Hackensack, NJ, USA have published the research: Improved Survival of Lymphoma Patients with COVID-19 in the Modern Treatment and Vaccination Era, in the Journal: Cancers 2022, 14, x FOR PEER REVIEW of 31/01/2022
- what: In this retrospective study the authors report the realworld outcomes of 68 lymphoma or CLL patients who developed COVID-19 infection during the omicron surge in the US.
- future: Studies are needed to better understand the benefit and scheduling of repeat COVID-19 vaccinations . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.